ME12 Meet the expert
Immunotherapies for lung cancer FULLY BOOKED
New diagnostic and therapeutic options
Registration for this session is additional to the congress registration fee and is €122 on site.
Aims : Access educational materials here
to provide profound insights into the new developments in the field of immunotherapy in lung cancer, and to describe solid diagnostic and therapeutic algorithms.
Target audience :
Clinical researcher, General practitioner, Nurse, Pathologist, Patient, Radiologist, Scientist (basic, translational), Student, Thoracic oncologist, Thoracic surgeon, Trainee, Adult pulmonologist/Clinician
Cell and molecular biology, General respiratory patient care, Imaging
Immunotherapies for lung cancer
T. Berghmans(Bruxelles, Belgium)
. . .